NRXS · ISSUER CIK 1933567
Neuraxis, INC
Between Jul 31, 2026 and Oct 28, 2026, 8 Neuraxis, INC insiders reported $12K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Henrichs Timothy Robert (Chief Financial Officer), with $9K.
↗8 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. No open-market sales in the window.
$12KInsider buying
$0.00Insider selling
+$12KNet open-market
Oct 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 202617:50 | Oct 8, 2026 | NRXS | Chief Executive Officer, Director | P · Buy | $4.84 | +268 | 227,604 | +0% | +$1K | -37.6% | +56.4% |
| Oct 8, 202617:47 | Oct 8, 2026 | NRXS | CRO, CCO, CPO | P · Buy | $4.84 | +328 | 199,673 | +0% | +$2K | -37.6% | +56.4% |
| Oct 8, 202617:45 | Oct 8, 2026 | NRXS | Chief Financial Officer | P · Buy | $4.84 | +1,937 | 9,530 | +26% | +$9K | -37.6% | +56.4% |
| Aug 26, 202617:30 | Aug 24, 2026 | NRXS | CRO, CCO, CPO | A · Grant | — | +193,678 | 199,345 | +3418% | — | ||
| Aug 26, 202617:30 | Aug 24, 2026 | NRXS | CMO, SVP Science & Tech | A · Grant | — | +199,106 | 199,106 | New | — | ||
| Aug 26, 202617:29 | Aug 24, 2026 | NRXS | Chief Executive Officer, Director | A · Grant | — | +199,188 | 227,336 | +708% | — | ||
| Aug 17, 202618:38 | Aug 13, 2026 | NRXS | Director | A · Grant | $6.28 | +26,073 | 72,408 | +56% | $164K | ||
| Aug 17, 202618:32 | Aug 13, 2026 | NRXS | Director | A · Grant | $6.28 | +26,073 | 72,408 | +56% | $164K | ||
| Aug 17, 202618:28 | Aug 13, 2026 | NRXS | Director | A · Grant | $6.28 | +31,134 | 67,072 | +87% | $196K | ||
| Aug 17, 202618:23 | Aug 13, 2026from Jul 29, 2026 | NRXS | Director | A · Grant | $3.20 | +86,224 | 80,058 | — | $276K |